Search Results - "Willbanks, Amber"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    EMT and tumor metastasis by Heerboth, Sarah, Housman, Genevieve, Leary, Meghan, Longacre, Mckenna, Byler, Shannon, Lapinska, Karolina, Willbanks, Amber, Sarkar, Sibaji

    Published in Clinical and translational medicine (26-02-2015)
    “…EMT and MET comprise the processes by which cells transit between epithelial and mesenchymal states, and they play integral roles in both normal development…”
    Get full text
    Journal Article
  2. 2

    RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases by Willbanks, Amber, Wood, Shaun, Cheng, Jason X

    Published in Genes (22-04-2021)
    “…Chromatin structure plays an essential role in eukaryotic gene expression and cell identity. Traditionally, DNA and histone modifications have been the focus…”
    Get full text
    Journal Article
  3. 3

    Exercise effects on DNA methylation in EVL, CDKN2A (p14, ARF), and ESR1 in colon tissue from healthy men and women by Duggan, Catherine, Yu, Ming, Willbanks, Amber R., Tapsoba, Jean de Dieu, Wang, Ching-Yun, Grady, William M., McTiernan, Anne

    Published in Epigenetics (03-10-2022)
    “…Physical activity reduces risk of colon cancer by 20-30%. Aberrant methylation patterns are common epigenetic alterations in colorectal adenomas, and cancers…”
    Get full text
    Journal Article
  4. 4

    A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis by Longacre, Mckenna, Snyder, Nicole A, Housman, Genevieve, Leary, Meghan, Lapinska, Karolina, Heerboth, Sarah, Willbanks, Amber, Sarkar, Sibaji

    “…Breast cancer persists as the most common cause of cancer death in women worldwide. Ovarian cancer is also a significant source of morbidity and mortality, as…”
    Get full text
    Journal Article
  5. 5

    Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk by Wang, Ting, Maden, Sean K, Luebeck, Georg E, Li, Christopher I, Newcomb, Polly A, Ulrich, Cornelia M, Joo, Ji-Hoon E, Buchanan, Daniel D, Milne, Roger L, Southey, Melissa C, Carter, Kelly T, Willbanks, Amber R, Luo, Yanxin, Yu, Ming, Grady, William M

    Published in Clinical epigenetics (03-01-2020)
    “…Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between…”
    Get full text
    Journal Article
  6. 6

    The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences by Willbanks, Amber, Leary, Meghan, Greenshields, Molly, Tyminski, Camila, Heerboth, Sarah, Lapinska, Karolina, Haskins, Kathryn, Sarkar, Sibaji

    Published in Genetics & epigenetics (01-01-2016)
    “…The evolution process includes genetic alterations that started with prokaryotes and now continues in humans. A distinct difference between prokaryotic…”
    Get full text
    Journal Article
  7. 7

    Rapid Analysis and Prediction of Drug Resistance in Leukemia By Novel Nascent RNA-Driven Flow Imaging Technologies and Biomarkers by Wood, Shaun, Willbanks, Amber, Cheng, Jason Xiaojun

    Published in Blood (23-11-2021)
    “…Background: Drug selectivity and resistance is a major obstacle to successful cancer therapy, including traditional chemotherapies (Vasan, N. et al. Nature…”
    Get full text
    Journal Article
  8. 8

    RNA Cytosine Methyltransferases NSUN1 and NSUN2 Mediate the Lineage-Associated Resistance to Venetoclax in Leukemia by Wood, Shaun, Willbanks, Amber, Cheng, Jason Xiaojun

    Published in Blood (05-11-2020)
    “…Background: Combinations of venetoclax/ABT-199, a small molecule that selectively inhibits anti-apoptotic protein BCL2, with hypomethylating agents (HMAs),…”
    Get full text
    Journal Article
  9. 9

    Harnessing the Systemic Biology of Functional Decline and Cachexia to Inform more Holistic Therapies for Incurable Cancers by Willbanks, Amber, Seals, Mina, Karmali, Reem, Roy, Ishan

    Published in Cancers (01-01-2024)
    “…Options for treatment of incurable cancer remain scarce and are largely focused on limited therapeutic mechanisms. A new approach specific to advanced cancers…”
    Get full text
    Journal Article
  10. 10

    Novel RNA epigenetics-driven technologies for rapid prediction of cancer drug resistance by Wood, Shaun, Willbanks, Amber, Tang, Derrick, Arber, Daniel A, Oakes, Scott, Shammo, Jamile M., Odenike, Olatoyosi, Stock, Wendy, Larson, Richard, Cheng, Jason X

    Published in Journal of clinical oncology (01-06-2023)
    “…e19001 Background: The human genome comprises ~99% non-coding DNA sequences (ncDNAs), most of which are actively transcribed into various forms of non-coding…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells by Lapinska, Karolina, Housman, Genevieve, Byler, Shannon, Heerboth, Sarah, Willbanks, Amber, Oza, Anuja, Sarkar, Sibaji

    Published in Anticancer research (01-11-2016)
    “…Ovarian cancer is difficult to treat due to absence of selective drugs and tendency of platinum drugs to promote resistance. Combination therapy using…”
    Get full text
    Journal Article
  13. 13
  14. 14